COEN, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 1.688
EU - Europa 344
AS - Asia 267
AF - Africa 33
SA - Sud America 18
OC - Oceania 3
Totale 2.353
Nazione #
US - Stati Uniti d'America 1.681
SG - Singapore 123
IT - Italia 90
IN - India 82
SE - Svezia 67
FI - Finlandia 61
CN - Cina 53
DE - Germania 43
UA - Ucraina 40
TG - Togo 27
BR - Brasile 11
GB - Regno Unito 10
RU - Federazione Russa 10
IE - Irlanda 7
CA - Canada 6
BG - Bulgaria 5
AR - Argentina 4
NZ - Nuova Zelanda 3
MA - Marocco 2
PT - Portogallo 2
RO - Romania 2
AL - Albania 1
BE - Belgio 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
FR - Francia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PL - Polonia 1
SC - Seychelles 1
TJ - Tagikistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 2.353
Città #
Fairfield 245
Chandler 187
Ashburn 122
Woodbridge 119
Singapore 88
Houston 86
Princeton 81
Cambridge 77
Seattle 77
Des Moines 73
San Paolo di Civitate 73
Wilmington 73
Ann Arbor 66
Dearborn 49
Boston 46
Plano 45
Lawrence 40
Santa Clara 29
Lomé 27
San Diego 19
Beijing 16
Helsinki 16
Andover 15
Falkenstein 14
Greifswald 13
Hefei 9
Millbury 9
Jacksonville 8
Dublin 7
Falls Church 7
Boardman 6
Feroleto Della Chiesa 6
Norwalk 6
Rome 6
Washington 6
Los Angeles 5
Mannheim 5
Sofia 5
Toronto 5
Bühl 4
Federal 4
Fremont 3
Kunming 3
Moscow 3
Nanchang 3
Nanjing 3
Auckland 2
Bremen 2
Chengdu 2
Fuzhou 2
Guangzhou 2
London 2
Abidjan 1
Almaty 1
Amman 1
Augusta 1
Bern 1
Blumenau 1
Brentford 1
Brussels 1
Buffalo 1
Changsha 1
Chicago 1
Colombo 1
Cosenza 1
Dallas 1
Dushanbe 1
Edinburgh 1
Fortaleza 1
Hamilton 1
Holon 1
Huzhou 1
Indiana 1
Irecê 1
Itajaí 1
Jieyang 1
Jinan 1
Jinhua 1
Johannesburg 1
Kilburn 1
Krumë 1
Laurel 1
Leawood 1
Lima 1
Lisbon 1
Nairobi 1
Oslo 1
Ottawa 1
Porto Alegre 1
Pune 1
Quzhou 1
Rabat 1
Rio de Janeiro 1
Santa Luzia 1
Shanghai 1
Shenyang 1
Sorocaba 1
Sucre 1
São José 1
Ubatuba 1
Totale 1.869
Nome #
Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate 92
Procollagen type I C-terminal extension peptide in predialysis chronic renal failure. 82
Immunohistochemical localization and mRNA expression of matrix Gla protein and fetuin-A in bone biopsies of hemodialysis patients 82
Effects of 1,25(OH)2D3 administration on serum bone GLA protein in predialysis chronic renal failure. 81
Relative roles of intestinal absorption and dialysis-fluid-related exposure in the accumulation of aluminium in haemodialysis patients 79
Calcium density measurement in histological samples of trabecular bone of normal subjects: relationship with aging. 74
Autonomic neuropathy and secondary hyperparathyroidism in uremia. 73
Biologic effect of 1,24(R)(OH)2D3 versus 1,25(OH)2D3 administration in chronic renal failure. 73
Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration. 72
Circannual versus seasonal variations of longitudinally sampled 25-hydroxycholecalciferol serum levels 71
Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study 69
Evaluation of osteoblastic activity by morphometric comparison of alkaline phosphatase cytochemistry vs. tetracycline fluorescence. 69
Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy. 68
Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients 67
Ischemic Nephropaty in an Elderly Nephrologic and Hypertensive Population 66
Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up. 65
No acceleration and possibly slower progression of renal failure during calcitriol treatment in predialysis chronic renal failure. 63
Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum-related bone disease. 61
Bone metabolism and its assessment in renal failure. 61
Extent of alkaline phosphatase cytochemistry vs. extent of tetracycline fluorescence in the evaluation of histodynamic variables of bone formation. 57
Andamento del volume osseo trabecolare con l'età e il sesso nell'insufficienza renale cronica 52
1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone. 52
Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment. 51
[Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis]. 45
[Assay of serum 24,25-dihydroxycholecalciferol by a competitive protein binding method]. 45
[Calcium-phosphorus changes in chronic anticonvulsant therapy: effects of the administration of 25-hydroxyvitamin D3 on secondary hyperparathyroidism]. 44
[Acebutolol as monotherapy of essential arterial hypertension]. 43
[Bone histomorphometry: methodological criteria in the study of metabolic skeletal diseases]. 43
Metabolic acidosis and osteodystrophic bone disease in predialysis chronic renal failure: effect of calcitriol treatment. 43
1-Alpha-OH-cholecalciferol (1-alpha-OHD3) and low phosphate diet in predialysis chronic renal failure: Effects on renal function and on secondary hyperparathyroidism 40
Diagnosi non invasiva della Nefropatia Ischemica nella popolazione anziana 39
Procollagen type 1 C-terminal extension peptide, PTH and 1,25 (OH) 2D3 in chronic renal failure. 38
[Serum 25-hydroxycholecalciferol and parathyroid function in the nephrotic syndrome]. 37
[Circannual rhythm of plasma 25-hydroxycholecalciferol in normal man]. 37
PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure. 36
Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia 36
Treatment with 1,25(QH)2D3 in predialysis chronic renal failure. 34
Effects of low doses of 1,25(OH)2D3 on bone histomorphometric parameters in predialytic chronic renal failure 34
Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure. 33
Severe vitamin D deficiency in a case of primary hyperparathyroidism caused by parathyroid lipoadenoma, effect of 25OHD3 treatment. 31
Intravenous versus oral calcitriol therapy in renal osteodystrophy: results of a prospective, pulsed and dose-comparable study. 29
[Hypoparathyroidism and Addison's disease with moniliasis: report of two cases in childhood (author's transl)]. 29
Plasma insulin-like growth factor-1 and bone formation parameters in predialysis chronic renal failure. 27
Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results. 23
Osteocalcin and biochemical and bone histomorphometric parameters in predialytic chronic renadssl failure 19
Totale 2.365
Categoria #
all - tutte 7.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020221 0 0 0 0 0 0 75 50 48 21 21 6
2020/2021145 13 10 5 12 55 5 1 11 11 5 16 1
2021/2022408 0 21 48 15 54 6 9 48 25 47 36 99
2022/2023665 117 169 5 69 62 127 15 29 49 6 14 3
2023/2024161 12 27 12 7 13 18 3 1 0 39 8 21
2024/2025183 37 5 19 8 57 57 0 0 0 0 0 0
Totale 2.365